Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Recruiting 4Active not recruiting 2Terminated 1Not yet recruiting 1Completed 1

Sponsor Class

OTHER 4

Study Type

Observational 2Interventional 2

Sponsor

Cancer Type

Thoracic 4

Conditions

NSCLC 1Lung Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Adenocarcinoma of Lung 1

Interventions

Specimen Handling 480pembrolizumab 455Magnetic Resonance Spectroscopy 420Carboplatin 327Cyclophosphamide 314Cisplatin 271Biopsy 271Radiotherapy 244Paclitaxel 229Gemcitabine 227Bevacizumab 213Nivolumab 188fludarabine 185venetoclax 174Drug Therapy 170Blood Specimen Collection 158Dexamethasone 157Oxaliplatin 154Injections 152Capecitabine 151Fluorouracil 144Docetaxel 144Radiosurgery 137Standard of Care 135Rituximab 125Pemetrexed 117durvalumab 115Leucovorin 109atezolizumab 107Radiation 106

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Recruiting × Anterior Temporal Lobectomy × 1 year × Clear all
NCT07612722 2026-05-29

Sub-lobectomy vs Lobectomy in IIA-IIIB NSCLC After Neoadjuvant IO+Chemo

Guangdong Provincial People's Hospital

Phase NA Recruiting
585 enrolled
Thoracic

NSCLC

NCT04937283 2026-04-13

Segmentectomy Versus Lobectomy for Lung Adenocarcinoma ≤ 2cm

Shanghai Pulmonary Hospital, Shanghai, China

Phase NA Recruiting
690 enrolled
Thoracic

Adenocarcinoma of Lung

NCT07166003 2025-09-10

NeoIP-Lung

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Recruiting
500 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT06483698 2025-08-29

EarlyLC-RW

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Recruiting
20,000 enrolled
Thoracic

Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡